Cancer Monoclonal Antibodies Market Poised for Breakthrough Growth Amid Rising Demand for Targeted Therapies 2025 | Top key players - Amgen Inc., Bristol Myers Squibb Company, Eli Lilly and Company.

Market Size and Growth:

The Cancer Monoclonal Antibodies Market size was valued at USD 46,474.80 million in 2021 and is estimated to reach a CAGR of 9.50% over the forecast period 2024-2031,

The Cancer Monoclonal Antibodies Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Cancer Monoclonal Antibodies market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/cancer-monoclonal-antibodies-market?sz

The Cancer Monoclonal Antibodies Market refers to the global industry focused on the development, production, and commercialization of monoclonal antibodies designed to target specific cancer cells. These therapies enhance immune response, block tumor growth, and improve patient outcomes. The market is driven by rising cancer prevalence, advancements in biotechnology, and increasing demand for targeted, personalized cancer treatments.

Key Developments of USA and Japan:

USA (June-September 2025):

June 18, 2025: FDA approved tafasitamab-cxix (Monjuvi) with lenalidomide and rituximab for relapsed or refractory follicular lymphoma.

July 2, 2025: FDA granted accelerated approval to linvoseltamab-gcpt (Lynozyfic), a bispecific antibody, for relapsed or refractory multiple myeloma.

Japan (June-September 2025):

August 2025: The MHLW granted orphan drug designation to tazemetostat for unresectable INI1-negative epithelioid sarcoma.

August 2025: Eisai initiated a rolling Supplemental Biologics License Application for a subcutaneous injection of LEQEMBI® IQLIKTM (lecanemab-irmb) for the treatment of early Alzheimer's disease.

Key Players:

Amgen Inc.
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Genmab AS
GlaxoSmithKline PLC
Johnson & Johnson
Novartis AG
Merck & Co., Inc
Spectrum Pharmaceuticals Inc.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=cancer-monoclonal-antibodies-market

Market Segmentation:

By Monoclonal Antibodies: Humanized, Murine, Chimeric, Human, Rat, Immunotoxin, Immunoadhesin, and Others.

By Therapies: Bevacizumab, Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), and Others.

By Application: Non-small-cell lung cancers, Breast Cancer, Blood Cancer, Liver Cancer, Brain Cancer, Colorectal Cancer, and Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/cancer-monoclonal-antibodies-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Cancer Monoclonal Antibodies market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Cancer Monoclonal Antibodies Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Cancer Monoclonal Antibodies market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Cancer Monoclonal Antibodies Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Cancer Monoclonal Antibodies Market in 2025?
◆ What is the projected growth rate of the Cancer Monoclonal Antibodies Market through 2033?
◆ Who are the key players in the Cancer Monoclonal Antibodies Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.